Telemental health company Brightside Health announced it raised $33 million dollars in Series C funding powered by healthcare-focused venture capital firm S32.
Kennedy Lewis, Time BioVentures, and 23andMe founder Anne Wojcicki participated in the round. Existing investors ACME, Mousse Partners and TriVentures also contributed.
The company confirmed the $33 million raise in an email to...
A Swiss technology company that specialises in smart containers for the sustainable transportation of pharmaceutical products, has just received significant investment from the United Arab Emirates (UAE), in a strategic round to increase growth in the Middle East and Far East regions.
SkyCell, which was founded in 2012, has secured $34.8 million (CHF 32 million) in Series C funding, in a...
Oviva, the digital health scaleup which provides diet and lifestyle coaching has announced that it has raised €67 million ($80m) in Series C funding to expand its digital diabetes treatment across Europe.
The round was co-led by Sofina and Temasek, alongside existing investors AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, and several angel investors.
WHY IT MATTERS
In Europe,...
Huma Therapeutics Ltd today announced the completion of its Series C funding round with financing of around $130 million.
Leaps by Bayer and Hitachi Ventures led the round, which also saw new strategic and financial investors become shareholders.
Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (...
CARESYNTAX SECURES €83M FOR AI HOSPITAL
Berlin-based healthtech company Caresyntax has raised €82.8 million ($100 m) in a Series C round. The investment was led by PFM Health Sciences LP, Optum Ventures, Intel Capital and Lauxera Capital Partners and is one of the largest rounds secured by a German healthtech company.
The company uses AI to digitise operation rooms by developing algorithms that...
New York-based Kaia Health has completed a €62 million ($75m) Series C funding round to expand clinical capabilities and treatment services for Musculoskeletal (MSK) and Chronic obstructive pulmonary disease (COPD) care in the US and Europe.
The total raised to date is €103 million ($125m), and was led by an unnamed growth equity fund with support from existing investors, including Optum Ventures...
